Evidence for oxidised low density lipoprotein in synovial fluid from rheumatoid arthritis patients

References

• Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. Journal of Biological Chemistry 1997; 272: 20963–20966
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis — an inflammatory disease. New England Journal of Medicine 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Rotheneder-Dieber M., Striegl G., Waeg G. Biochemical, structural, and functional proterties of oxidized low-density lipoprotein. Chemical Research in Toxicology 1990; 3: 77–92
   PubMed Web of Science ®Google Scholar
• Pentikainen M.O., Lehtonen E.M., Kovanen P.T. Aggregation and fusion of modified low density lipoprotein. Journal of Lipid Research 1996; 37: 2638–2649
   PubMed Web of Science ®Google Scholar
• Smith C., Mitchinson M.J., Aruoma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochemical Journal 1992; 286: 901–905
   PubMed Web of Science ®Google Scholar
• Lamb D.J., Mitchinson M.J., Leake D.S. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Letters 1995; 374: 12–16
   PubMed Web of Science ®Google Scholar
• Hiramatsu K., Rosen H., Heinecke J.W., Wolfbauer G., Chait A. Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis 1987; 7: 55–60
   PubMedGoogle Scholar
• Parthasarathy S., Wieland E., Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proceedings of the National Academy of Sciences USA 1989; 86: 1046–1050
   PubMed Web of Science ®Google Scholar
• Daugherty J.L., Dunn D.L., Rateri, Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. Journal of Clinical Investigation 1994; 94: 437–444
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Annals of the Rheumatic Diseases 1995; 54: 505–510
   PubMed Web of Science ®Google Scholar
• Winyard P.G., Blake D.R. Antoxidants, redox-regulated transcription factors, and inflammation. Advances in Pharmacology 1997; 38: 403–421
   PubMedGoogle Scholar
• Winyard P.G., Tatzber F., Esterbauer H., Kus M.L., Blake D.R., Morris C.J.M. Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 1993; 52: 677–680
   PubMed Web of Science ®Google Scholar
• Dai L., Zhang Z., Winyard P.G., Gaffney K., Jones H., Blake D.R., Morris C.J. A modified form of low density lipoprotein with increased electronegative charge is present in rheumatoid arthritis synovial fluid. Free Radical Biology and Medicine 1997; 22: 705–710
   PubMedGoogle Scholar
• Schacterle G.R., Pollack R.L. A simplified method for the quantitative assay of small amounts of protein in biological material. Analytical Biochemistry 1973; 51: 654–655
   PubMed Web of Science ®Google Scholar
• David L.J., Leake D.S. The effect of EDTA on the oxidation of low density lipoprotein. Atherosclerosis 1992; 94: 35–42
   Google Scholar
• Morris C.J., Walton K.W. Low density lipoprotein sizes in hyperlipidaemias. Latent dyslipoproteinaemias and atherosclerosis, J.L. deGennes, J. Polonowski, R. Paoletti. Raven Press, New York 1984; 51–63, In
   Google Scholar
• de Whalley V., Rankin S.M., Hoult J.R., Jessup W., Leake D.S. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochemical Pharmacology 1990; 39: 1743–1750
   PubMed Web of Science ®Google Scholar
• Wilkins G.M., Leake D.S. The effect of inhibitors of free radical generating enzymes on low density lipoprotein oxidation by macrophages. Biochimica et Biophysica Acta 1994; 1211: 69–78
   PubMedGoogle Scholar
• James MJ., van Reyk D., Rye K.A., Dean R.T., Cleland L.G., Barter P.J., Jessup W. Low density lipoprotein of synovial fluid in inflammatory joint disease is mildly oxidized. Lipids 1998; 33: 1115–1121
   PubMed Web of Science ®Google Scholar
• Viikari J., Jalava S., Terho T. Synovial fluid lipids in rheumatoid arthritis. Scandinavian Journal of Rheumatology 1980; 9: 164–166
   PubMed Web of Science ®Google Scholar
• Chen G., Hardman D.A., Hamilton R.L., Mendel C.M., Schilling J.W., Zhu S., Lau K., Wong J.S., Kane J.P. Distribution of lipid-binding region in human apolipoprotein B-100. Biochemistry 1989; 28: 2477–2484
   Google Scholar
• Haberland M.E., Fogelman A.M., Edwards P.A. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proceedings of the National Academy of Sciences USA 1982; 79: 1712–1716
   PubMed Web of Science ®Google Scholar
• Henriksen T., Mahoney E.M., Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 1983; 3: 149–159
   PubMedGoogle Scholar
• Dieppe P., Blake D.R. Inflammation. Copeman's Texbook of the Rheumatic Diseases, J.T. Scott. Churchill Livingstone Press, London 1986; 281–301, In
   Google Scholar
• Small M., Cohen A.S., Schmid K. Lipoproteins of synovial fluid as studied by analytical ultracentrifugation. Journal of Clinical Investigation 1964; 43: 2070–2079
   Google Scholar
• Farr M., Garvey K.G., Bold A.M., Kendall M.J., Bacon P.A. Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis. Clinical and Experimental Rheumatology 1985; 3: 99–104
   PubMed Web of Science ®Google Scholar
• Leake D.S. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?. Atherosclerosis 1997; 129: 149–157
   PubMed Web of Science ®Google Scholar
• Meier B., Radeke H.H., Selle S., Raspe H.H., Sies H., Resch K., Habermehl G.G. Human fibroblasts release reactive oxygen species in response to treatment with synovial fluids form patients suffering from arthritis. Free Radical Research Communications 1990; 8: 149–160
   PubMed Web of Science ®Google Scholar
• Blake D.R., Merry P., Unsworth J., Outhwaite J., Morris C.J., Gray L., Lunec J. Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1989; I: 289–293
   Web of Science ®Google Scholar
• Blake D.R., Bacon P.A.E., Astham E.J., Brigham K. Synovial fluid ferritin in rheumatoid arthritis. British Medical Journal 1980; 281: 715–716
   PubMed Web of Science ®Google Scholar
• Winyard P.G., Blake D.R. Caeruloplasmin and oxygen free radicals. Free Radicals, Metal Ions and Biopolymers, P.C. Beaumont, D.J. Deeble, C. Rice-Evans. Richelieu Press, London 1989; 83–197, In
   Google Scholar
• Lamb D.J., Leake D.S. Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein. FEBS Letters 1994; 338: 122–126
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay C.K., Ehrenwald E., Fox P.L. Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism. Journal of Biological Chemistry 1996; 271: 14773–14778
   PubMedGoogle Scholar
• Gutteridge J.M.C., Richmond R., Halliwell B. Oxygen free radicals and lipid peroxidation. Inhibition by the protein caeruloplasmin. FEBS Letters 1980; 112: 269–272
   Web of Science ®Google Scholar
• Dai L., Winyard P.G., Zhang Z., Blake D.R., Morris C.J. Ascorbate promotes low density lipoprotein oxidation in the presence of ferritin. Biochimica et Biophysica Acta 1996; 1304: 223–228
   PubMedGoogle Scholar